TerminatedNot Applicable

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Stopped: Practice change in what is considered standard of care

United States8 participantsStarted 2016-03-18

Plain-language summary

The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care. Exclusion Criteria: •Subject is \<18 years old.

What they're measuring

Overall Survival (OS)

Timeframe: 2 years

Trial details

NCT IDNCT02613312

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-10-05

View on ClinicalTrials.gov More Mesothelioma trials